238 related articles for article (PubMed ID: 35836886)
41. Integrative analysis of cancer driver genes in prostate adenocarcinoma.
Zhao X; Lei Y; Li G; Cheng Y; Yang H; Xie L; Long H; Jiang R
Mol Med Rep; 2019 Apr; 19(4):2707-2715. PubMed ID: 30720096
[TBL] [Abstract][Full Text] [Related]
42. Utilizing Ubiquitination Patterns to Predict Prostate Cancer Prognosis and Devise a Therapeutic Response.
Zhang X; Wang Y; Chang Y; Wang J; Yan S; Xiao Y; Guo T; Lou Y; Ma J; Xu W; Ren S
Arch Esp Urol; 2023 May; 76(3):215-231. PubMed ID: 37340527
[TBL] [Abstract][Full Text] [Related]
43. A Novel Model Based on Necroptosis-Related Genes for Predicting Prognosis of Patients With Prostate Adenocarcinoma.
Li XY; You JX; Zhang LY; Su LX; Yang XT
Front Bioeng Biotechnol; 2021; 9():814813. PubMed ID: 35111740
[No Abstract] [Full Text] [Related]
44. Identification of the hub genes and prognostic indicators of gastric cancer and correlation of indicators with tumor-infiltrating immune cell levels.
Ji Y; Gao L; Zhang C; Sun X; Dai L; Ji Z; Zhang J; Zhang Z; Cao W; Zhao Y; Zhang L
J Cancer; 2021; 12(13):4025-4038. PubMed ID: 34093807
[No Abstract] [Full Text] [Related]
45. Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine.
Zheng X; Xu H; Yi X; Zhang T; Wei Q; Li H; Ai J
Mol Cancer; 2021 Dec; 20(1):160. PubMed ID: 34872584
[TBL] [Abstract][Full Text] [Related]
46. Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer.
He T; Zhang Y; Li X; Liu C; Zhu G; Yin X; Zhang Z; Zhao K; Wang Z; Zhao P; Wang K
World J Surg Oncol; 2022 Jun; 20(1):174. PubMed ID: 35650630
[TBL] [Abstract][Full Text] [Related]
47. Identification of FAM107A as a potential biomarker and therapeutic target for prostate carcinoma.
Ma YF; Li GD; Sun X; Li XX; Gao Y; Gao C; Cao KX; Yang GW; Yu MW; Wang XM
Am J Transl Res; 2021; 13(9):10163-10177. PubMed ID: 34650688
[TBL] [Abstract][Full Text] [Related]
48. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
[TBL] [Abstract][Full Text] [Related]
49. Meta-analysis identifying epithelial-derived transcriptomes predicts poor clinical outcome and immune infiltrations in ovarian cancer.
Li DF; Tulahong A; Uddin MN; Zhao H; Zhang H
Math Biosci Eng; 2021 Jul; 18(5):6527-6551. PubMed ID: 34517544
[TBL] [Abstract][Full Text] [Related]
50. Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma.
Qiao S; Zhang W; Su Y; Jiang Y
Front Oncol; 2022; 12():1037535. PubMed ID: 36591519
[TBL] [Abstract][Full Text] [Related]
51. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
Hammad A; Elshaer M; Tang X
Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
[TBL] [Abstract][Full Text] [Related]
52. High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis.
Deng H; Hang Q; Shen D; Ying H; Zhang Y; Qian X; Chen M
Front Mol Biosci; 2021; 8():653805. PubMed ID: 34307447
[No Abstract] [Full Text] [Related]
53. Integrative analyses of molecular pathways and key candidate biomarkers associated with colorectal cancer.
Pirim D
Cancer Biomark; 2020; 27(4):555-568. PubMed ID: 32176635
[TBL] [Abstract][Full Text] [Related]
54. ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma.
Qiu W; Wu X; Shi H; Liu B; Li L; Wu W; Lin J
Front Oncol; 2022; 12():678025. PubMed ID: 35174076
[TBL] [Abstract][Full Text] [Related]
55. Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils the Characteristics of the Immune Microenvironment and Prognosis Signature in Prostate Cancer.
Wang R; Xiao Y; Pan M; Chen Z; Yang P
J Oncol; 2022; 2022():6768139. PubMed ID: 35909899
[TBL] [Abstract][Full Text] [Related]
56. Single-cell and bulk RNA-sequencing reveals mitosis-involved gene HAUS1 is a promising indicator for predicting prognosis and immune responses in prostate adenocarcinoma (PRAD).
Liu S; Yu Y; Xu J; Wang Y; Li D
Cell Biol Int; 2024 May; ():. PubMed ID: 38818762
[TBL] [Abstract][Full Text] [Related]
57. Molecular mechanisms, immune cell infiltration, and potential drugs for prostate cancer.
Yan Y; Mao X; Zhang Q; Ye Y; Dai Y; Bao M; Zeng Y; Huang R; Mo Z
Cancer Biomark; 2021; 31(1):87-96. PubMed ID: 33780364
[TBL] [Abstract][Full Text] [Related]
58. Identification and Validation of Prognostic Biomarkers Specifically Expressed in Macrophage in IgA Nephropathy Patients Based on Integrated Bioinformatics Analyses.
Ding Y; Li H; Xu L; Wang Y; Yang H
Front Mol Biosci; 2022; 9():884588. PubMed ID: 35601837
[No Abstract] [Full Text] [Related]
59. Identification of key gene modules and hub genes of human mantle cell lymphoma by coexpression network analysis.
Guo D; Wang H; Sun L; Liu S; Du S; Qiao W; Wang W; Hou G; Zhang K; Li C; Teng Q
PeerJ; 2020; 8():e8843. PubMed ID: 32219041
[TBL] [Abstract][Full Text] [Related]
60. Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches.
Chen H; Wu J; Lu L; Hu Z; Li X; Huang L; Zhang X; Chen M; Qin X; Xie L
Front Genet; 2020; 11():575762. PubMed ID: 33505422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
